Parikh, N. K., Parmar, B., Shree, A., Saparov, D., Leiva, K. E., Jora, G., Biswas, S. (2026). Inotuzumab ozogamicin versus blinatumomab in pediatric relapsed/refractory CD22-positive B-cell acute lymphoblastic leukemia: A systematic review and meta-analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e18512